Navenio secures £50,000 UK Fast Start funding http://dlvr.it/RXpWBh
We are delighted to announce the official launch of Base Genomics and that we have closed a seed funding round of $11 million USD to support development of our breakthrough technology towards a highly sensitive blood test for cancer.
Welcome to the portfolio @BaseGenomics and congrats to Oliver Waterhouse, former EiR at OSI! 🧬
Borne out of the Ludwig Institute for Cancer Research Branch at the @UniofOxford, TAPS technology sets a new gold standard in DNA methylation sequencing.
OSI // A thousand years of the future.
For all enquiries: firstname.lastname@example.org
46 Woodstock Road,
Oxford, OX2 6HT
© Oxford Sciences Innovation 2020